Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02590029 · ClinicalTrials.gov registry record · NA
Psychosocial Support for Acute Hospital Pain and Distress
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 244
- Enrollment target
NCT02590029: Completed NA study, sponsored by University of Utah.
NCT02590029 is a NA study that has completed, run by University of Utah. The registered enrollment target is 244 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02590029, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 244 participants
- Enrollment target
Study Summary
The purpose of this randomized study is to determine the impact of three different types of psychosocial support delivered by social workers to patients reporting uncontrolled pain during a hospital stay. This study will examine the differential effects of brief mindfulness training, therapeutic suggestion, and psychoeducation for patients reporting uncontrolled pain.
Primary Outcome
0-10 scale
Interventions
- BEHAVIORAL Psychoeducation
- BEHAVIORAL Mindfulness
- BEHAVIORAL Suggestion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 244 participants |
| Start Date | 2015-11 |
| Est. Completion | 2018-10 |
| Phase | NA |
What the finished NCT02590029 record still lists
NCT02590029 is an interventional study that assigns participants to a tested intervention. The registered 244 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 3 interventions - of which Psychoeducation is the first listed.
NCT02590029 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02590029 about?
NCT02590029 is a clinical study titled "Psychosocial Support for Acute Hospital Pain and Distress". The purpose of this randomized study is to determine the impact of three different types of psychosocial support delivered by social workers to patients reporting uncontrolled pain during a hospital stay. This study will examine the differential effects of brief mindfulness training, therapeutic sug...
What is the current status of trial NCT02590029?
This trial is currently completed. It is a NA study. The enrollment target is 244 participants. The study started on 2015-11. Estimated completion is 2018-10.
What interventions are being tested in trial NCT02590029?
The interventions under investigation include: Psychoeducation (BEHAVIORAL), Mindfulness (BEHAVIORAL), Suggestion (BEHAVIORAL).
Who is sponsoring clinical trial NCT02590029?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02590029's enrollment target sits among peer trials
244 438th of 2000 higher than 1,563 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02227251 · 244 participants · Phase 2
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
- NCT04317534 · 244 participants · Phase 2
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
- NCT04683250 · 244 participants · Phase 1
Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities
- NCT04686305 · 244 participants · Phase 1
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia